Brain Canada and the Azrieli Foundation call for proposals
Brain Canada is pleased to announce The Azrieli Neurodevelopmental Research Program, Multi-Investigator Research Initiative (MIRI).
The Azrieli Foundation in partnership with Brain Canada will support excellent systems or translational research in the area of neurodevelopmental disorders, with a special focus on ASD and Fragile X syndrome. The ultimate goal of the initiative is to develop new diagnostics, treatment and prevention strategies for neurodevelopmental disorders, to reduce their economic and social burden on Canadians, and to improve the quality of life for those affected by neurodevelopmental disorders and their families.
Over the next five years, $7.5 million will be provided by The Azrieli Foundation and Brain Canada, through the Canada Brain Research Fund.
The OVPR Internal Deadline for letters of intent is March 21, 2013. The External Deadline for letters of intent, April 5, 2013
The OVPR Internal Deadline for full applications is August 2, 2013. The External Deadline for full applications is August 16, 2013.
Please direct all letters of intent and full proposals along with the OR-5 and its supporting documentation (ie letters of support if required and budget with indirect costs included) to the Office of Research.
The funding is to begin on or after November 18, 2013.
Request for Applications: NEURODEV_MIRI_RFA_EN.pdf
For further Information:
About Brain Canada and the Canada Brain Research Fund: http://braincanada.ca/
About this competition: Neurodev@braincanada.ca
The funding announcement and further information about this call are posted below.
|Azrieli Neurodev MIRI announcement.pdf||41.26 KB|
|Azrieli Neurodev MIRI announcement french.pdf||168.57 KB|